Google TrendNOVIG (2000+) — Novig Sign Up Bonus: ROTOWIRE Gets $50 in Trade Credits
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Exploring New CAR-T Appro" (30 stories)

Top Headline Story

Driving CAR T-cell Therapy in New Directions | Blog | AACR
Lead StoryAmerican Association for Cancer Researchgeneral
Aug 25

Driving CAR T-cell Therapy in New Directions | Blog | AACR

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxOUkI0QmJ0b1JacDRrdEMtNXV5WjBlTkhqSFl4YVlWbTlWazgtT25YUm53b210TGhzbm9RRzNIWWxETmQycUxZU1gzdTJoa21ncHpqNWFRTnJCTnhLTHdtYnZjcDE1ZVA0QjdCdGt1QjIwdmVWbWV0YkUxaTk3Z3N0N0lLcHdxcnZaU1E?oc=5" target="_blank">Driving CAR T-cell Therapy in New Directions | Blog | AACR</a>  <font color="#6f6f6f">American Association for Cancer Research</font>

Real-time search volume
2000+23m ago

novig

Novig Sign Up Bonus: ROTOWIRE Gets $50 in Trade Credits

500+23m ago

boise state vs fresno state

Boise State gets big health boost, but injury concerns remain vs. Fresno State

500+23m ago

sounders

NEvsSEA Starting XI: Dejan Joveljić and Yeimar return to starting lineup, Sebastian Gomez gets the nod

200+23m ago

pedro pascal

Pedro Pascal in ‘Behemoth!’: The Oscar-Worthy Role That He (and Latinos) Have Been Waiting For

Search Results for "Exploring New CAR-T Appro"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
AI-driven approach identifies promising new target for CAR T cell therapy
News-Medicaltech

AI-driven approach identifies promising new target for CAR T cell therapy

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOMmNwVkktUEFaSG95ajdQSXk5c3F2Ql8tMUhMYWhSZFo0azRRWG0yQlpXbE5wWmczOTVUbzB1YUR3UXZ5dDVFOTFJOV8zSkNEcVQ4OUtWNTU5blpWc2JqTVFIRVQ4MkV0cUlKS01CRVJpWUY0ckI0T0dNMS1DM3dUTlVFSnJQbnI0SFhxNWxfaXhKVFpWOUd2SHFZd1QtcXFkaHRZUDJjdFFNdllFY1p5c21ua0kweGpyV0NIb2lB?oc=5" target="_blank">AI-driven approach identifies promising new target for CAR T cell therapy</a>  <font color="#6f6f6f">News-Medical</font>

Radiopharmaceutical could help CAR-T cells reach solid tumors
Oncology Centralgeneral

Radiopharmaceutical could help CAR-T cells reach solid tumors

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxNQXFYYTlFMGdTSkxkVmxfSG1KQmdTdGlfMXNlTGxUa3V3S1BQb2VxREpyTnVSYVU0Q0xIWXBPVGR2NDdzUGVJSldmSlE2Um5OQV8tQXItUzRUTE43ZWRha29mbmdPQVhEZ3piN0kwd216eHNLcXlFRHRJX0tuMllwU2NkMWhVVTF4VFhBY1hWM2FRSE5XUjBscHZLNA?oc=5" target="_blank">Radiopharmaceutical could help CAR-T cells reach solid tumors</a>  <font color="#6f6f6f">Oncology Central</font>

New approach could expand CAR T therapy from blood cancers to solid tumors
Medical Xpressgeneral

New approach could expand CAR T therapy from blood cancers to solid tumors

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxNb1kta1lQUjJhT2R5NVZnRmlXUWdJQjZ6SVZIdjAxRzkzeDRkUDBjTW9Tallic3ZnbnZDeS0zbkV0X05lT3BjeTFfNEU2SVlYSEZXcVFOZXFqRVFESlBsNXlkZnliUm02NXRIQlA1djRTUmdQZDl5RG5sU2t2SHlOQm81TUc?oc=5" target="_blank">New approach could expand CAR T therapy from blood cancers to solid tumors</a>  <font color="#6f6f6f">Medical Xpress</font>

A New Look At Legend Biotech: Plenty Of Upside For Carvykti (NASDAQ:LEGN)
Seeking Alphatech

A New Look At Legend Biotech: Plenty Of Upside For Carvykti (NASDAQ:LEGN)

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPWlZqamxkSkc0cG9sQlZBZlVSUHREdnphcHlqaW9hdlZlNGhkcW9UMFZscDBGTVFZclpSNDlCbnhPd0x2SjNPRkZTTmtucFFPRUFqb0pubmxtLXBZQ3p3WjN5a1dnbHI2WTBJWjFuaDI5TldGTWRLbmtZaV9LdmZ6RGV2UnI2a1g5Q2FfUlU4bDFHY080NmZfaW1GU0hOc0lU?oc=5" target="_blank">A New Look At Legend Biotech: Plenty Of Upside For Carvykti (NASDAQ:LEGN)</a>  <font color="#6f6f6f">Seeking Alpha</font>

New strategy creates CAR-T cells inside the body
Duke School of Medicinegeneral

New strategy creates CAR-T cells inside the body

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxQRVhkZ0Zrcm11WmJELUttMTU4cGxiQTR0bHNOdGh3dWx1Qnp4UnpYVVA2dVFSWHFscjdIYXV5VHZ2MXdBMWhyN2VJQXdrN0M1QkRScnNvd3ZISmc2a0taSnZTRmFHdnJUOHVVZS1yb082aTBlWWMwUzVDTEJ0OTU2Vnl3?oc=5" target="_blank">New strategy creates CAR-T cells inside the body</a>  <font color="#6f6f6f">Duke School of Medicine</font>

FDA to require CAR-T developers conduct randomised controlled trials
FirstWord Pharmageneral

FDA to require CAR-T developers conduct randomised controlled trials

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE9IbFFWczF5UWsxTl9SUWVMQkxETVJFU0duYWRxZDhFYVJyVFhvbGNJNVR1WXJtcHE2ZkZYRF9uLXZVR3BLcjVHcmNDaGFlaU9JQU5F?oc=5" target="_blank">FDA to require CAR-T developers conduct randomised controlled trials</a>  <font color="#6f6f6f">FirstWord Pharma</font>

Orca-T Plus Allogeneic CD19/22 CAR T-Cell Therapy Merits Further Exploration in High-Risk B-ALL
OncLivegeneral

Orca-T Plus Allogeneic CD19/22 CAR T-Cell Therapy Merits Further Exploration in High-Risk B-ALL

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPaEFjNFZfUGNVdm1KTUhrekhBd0c5alR1X2FJRHBSR05EWGVEYVNFMmdRT0JORlNyc1U0Y2RSemRheGUtbTJCYlVhbXd6VkdWU1NkUjV5MUg1XzF2V1JsaEN0ekRYWTdpdXVRb01hLVRxX3lGQWYzT1p4dmpscUtFMTBGMFNzTXNWRm1QMnpab19XZk0tNHFUaHpnSkE4bVlnU0ZYWHFzOWRCeVZoY2dhc1RMTEtCQTZvUUh4QUZ1RmwzQQ?oc=5" target="_blank">Orca-T Plus Allogeneic CD19/22 CAR T-Cell Therapy Merits Further Exploration in High-Risk B-ALL</a>  <font color="#6f6f6f">OncLive</font>

ASH 2025: New combination approach aims to make CAR T more durable in lymphoma
EurekAlert! Science News Releasestech

ASH 2025: New combination approach aims to make CAR T more durable in lymphoma

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFBtbnZQeGdHRk9RZ1FMY3N4UFplRndBMHozekhNX2lwSGJHMEktSEFyWVBhNWFDNlpPdWFIUjNaSkx3QjYwbUwzeU1oY09rak0wbjJmVVpjUkoxQ2Z2?oc=5" target="_blank">ASH 2025: New combination approach aims to make CAR T more durable in lymphoma</a>  <font color="#6f6f6f">EurekAlert! Science News Releases</font>

Scientists explore new frontier in autoimmune disease treatment by resetting 'rogue' cells
PBSworld

Scientists explore new frontier in autoimmune disease treatment by resetting 'rogue' cells

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNLXBISE5GSFVSU0J3LXdlTUpVcmZsb1gtcU1MRFlCSW81UUVRNUMtaWVqVV9ESTJuYXJGYXg4SjZDY0Fsa01waU53bUZkYUJsZUJ5eVFZc3I3bVRQejBJQXIxaVRZWFMyVmx2ZHRyZy1HQnJqa1dVeW1HSzFkV3NzN2ZkeXkyWGZ6WnJtUElyWnRQUm1tS1Zpb1Ryc3dnRnN1NGJNRmdINU1WTnJpcjRQUkk0U1FWMFRYcmR2bkhIMnVnUQ?oc=5" target="_blank">Scientists explore new frontier in autoimmune disease treatment by resetting 'rogue' cells</a>  <font color="#6f6f6f">PBS</font>

Michel Sadelain: “Living Medicine” Pioneer Explores New Frontiers at Columbia
Columbia University Irving Medical Centertech

Michel Sadelain: “Living Medicine” Pioneer Explores New Frontiers at Columbia

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQ2dQZzZub0o0dlZZeDRSTUdxdmpDNDhVVVBjRXBkZjQxTjZPcnpma2JvOThZNzFHQzFDNWlvTG1EMlhHdUNtdTl2NHJqRnBxY3I5YUxjdkNTWUY1SWZrekRpWm8tY0ttenlYSEt0MnRzRGN3eW5Hc2ViQ3lyaDc0TTQ5cTUyOXVzOVBYSEZ1R05aYUdmZmxrVFptaGJaYXpxbXN1Y1V1QTFhSVU?oc=5" target="_blank">Michel Sadelain: “Living Medicine” Pioneer Explores New Frontiers at Columbia</a>  <font color="#6f6f6f">Columbia University Irving Medical Center</font>

Using CAR-T cells to treat ovarian cancer
Stanford Medicinegeneral

Using CAR-T cells to treat ovarian cancer

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxOTnJjR2lQNVVlaDJvOURfM29sQXdFRUZ5TXo3b20yRWVlREhmNUdJWUFaVGVlTkJVMWlURjljU1B3NmVpU2xOZHZkbnk0OWhjSHRTUDU4MGU5Z0c4emdsSHBTMVVNVm9uNGxpTXBfN2N4cU1WbVJFVUtQTWhxUzMybzhFZnJubTZGVU9lQVgzaU9YUXc?oc=5" target="_blank">Using CAR-T cells to treat ovarian cancer</a>  <font color="#6f6f6f">Stanford Medicine</font>

CAR T therapies in multiple myeloma: unleashing the future - Cancer Gene Therapy
Natureworld

CAR T therapies in multiple myeloma: unleashing the future - Cancer Gene Therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBHVFBhSVM0dy1PVzFCVmdwNHN4LTZ2VEtHdkowZENKUVNpaXIyYWZsMFdsVWo0NXU5TGlDNU5WUEtrMlJSZThhaHR3Zm5IWVVVUlRDcXhtaVMzZFpodTVv?oc=5" target="_blank">CAR T therapies in multiple myeloma: unleashing the future - Cancer Gene Therapy</a>  <font color="#6f6f6f">Nature</font>

Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment Strategies
CancerNetworkgeneral

Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment Strategies

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNcktjcWtkYWZzRS1mNllBbktZenQ5OUlQRkpWeVlqbURKT21DaFdDalk1ekhWTkdFcXgxc1REbFpYX2d1QWZROWRtYmlZU3lEeVlWNzlTc0dBNFIyUkxyQlVnSldwQ1JXYU9iM1JsSi0xWlFjS1pGMGxKU3AwOW9EdXpES2cxeGZaT05sdzVXVEdVUVJwZXJmRXBWcDhsbU51VmUxLUF1bW9xUzR0N21ydEpHSWdVN1lIWG1fbmVxV2c?oc=5" target="_blank">Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment Strategies</a>  <font color="#6f6f6f">CancerNetwork</font>

New CAR T strategy targets most common form of heart disease
Penn Medicinegeneral

New CAR T strategy targets most common form of heart disease

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQTnFQa2Z5eVNCZjZvMk1EM0o4bnBsQWFEYzVVdTBjOGhUMk5sRWl3cTVWVHU0ZFZ3bllRRVdIbnQ1QVRRZ2g1NUpuLWRuN0VCTDdQNEJhbTV1WjdNN0lBbkg0d3AtVTl5UDJrY05mRjRNVGV3ekI2YlFXaE1IU01RczZHYXo5UE5fWm9HR3RDV3VGcW01UzdrdWNn?oc=5" target="_blank">New CAR T strategy targets most common form of heart disease</a>  <font color="#6f6f6f">Penn Medicine</font>

New CAR T-Cell Trial Launched Through Gates Institute Packages Two CARs in One Treatment
University of Colorado Anschutzworld

New CAR T-Cell Trial Launched Through Gates Institute Packages Two CARs in One Treatment

<a href="https://news.google.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?oc=5" target="_blank">New CAR T-Cell Trial Launched Through Gates Institute Packages Two CARs in One Treatment</a>  <font color="#6f6f6f">University of Colorado Anschutz</font>

Cell Therapy Weekly: In Vivo CAR-T Therapy Moves Forward
RegMedNetgeneral

Cell Therapy Weekly: In Vivo CAR-T Therapy Moves Forward

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxPSGNra2hDazc3T29lT1ViSlFVY3RFSG50V3VPWTFfa0h5QmtfWTFUdVBjQlhjZkRCc1FVanBUMTV6STZkbDRuOENLWXZ6VXlDb0NVS3ZFUnVpZ1U5cTBZUVpfTG1tbzFPZERHRlJhWVFES3piVG0xS2g5MFlNRDREVWMwYl9BNkdKeFE?oc=5" target="_blank">Cell Therapy Weekly: In Vivo CAR-T Therapy Moves Forward</a>  <font color="#6f6f6f">RegMedNet</font>

CAR T-Cell Therapy: New Advances Move On Past Setbacks
Genetic Engineering and Biotechnology Newsgeneral

CAR T-Cell Therapy: New Advances Move On Past Setbacks

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPUWdUQlJJVWNPSGpPdGZwa2xsdzF2M3BUcXpQTXNQNjFJWS1MX19mZFhHSURUUVZHNHhFek12MkVoN3ZDSlJnYTUtQ1hOZ3poVGlaekFKVEd3ckY1Skh2WnZwMGpUMDA4SW9zbnZpLVlJTnZHME9XZXhYalZ4RHRGaXhYUGNaXzdLZERyTkdVdk1CcXFteFFnRDR4dw?oc=5" target="_blank">CAR T-Cell Therapy: New Advances Move On Past Setbacks</a>  <font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>

How future cures begin as ideas in laboratories
Penn Medicinegeneral

How future cures begin as ideas in laboratories

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxOV0RSa0lxcGU1UW9FaTJxZmJiMWtRN0RwcmEtZ0xLMWxpdEI3UW51aFpEN054QzM1ZmItU29Xa3d2VjQ5bTNSaUI0RG02ZXJhdFZxUjliSnBuMzY2LTFIVFJtUTFIZmVRX3VzaEM2NE1tQTJKQzFPVkR5RWpQSFVEMG9fT1ZyeG0y?oc=5" target="_blank">How future cures begin as ideas in laboratories</a>  <font color="#6f6f6f">Penn Medicine</font>

Early-career Investigator Aims to Transform Leukemia Treatment with a Novel Approach to CAR T-cell Therapy
University of Colorado Anschutztech

Early-career Investigator Aims to Transform Leukemia Treatment with a Novel Approach to CAR T-cell Therapy

<a href="https://news.google.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?oc=5" target="_blank">Early-career Investigator Aims to Transform Leukemia Treatment with a Novel Approach to CAR T-cell Therapy</a>  <font color="#6f6f6f">University of Colorado Anschutz</font>

Reconsidering Post-CAR-T Therapy Monitoring Requirements
Hematology Advisorgeneral

Reconsidering Post-CAR-T Therapy Monitoring Requirements

<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTE5Nb04yQ1NNeDA4UmNtWS0wOTRoU21UXzFOcjFUMFlMUk9xVjlocU93ODVaaVM3Vk1KTktEQ0lpVENQV1R4dGl0Qkl5T0E5clNkT0NPVC1QRlE4TUxpcDhyMzBfQm94ajJhZFcyVkFrQmd3cDFBdnNaTlZhanFueW8?oc=5" target="_blank">Reconsidering Post-CAR-T Therapy Monitoring Requirements</a>  <font color="#6f6f6f">Hematology Advisor</font>

Why new cancer treatment discoveries are proliferating
Penn Medicinegeneral

Why new cancer treatment discoveries are proliferating

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNNUVuNjVUTmRRZjQ5QnRTWVNOc2EydG9oM3YtM3hhT2JqeWJHZi1BR0NEdUpEb1pTd1JBWTdYY3Bnc0t4RHpzZWZpamNDNUFpOER3dDZrR05mdG9Ea19abzhJWHFTUWd1dzhVdVktckRmS3pfZHg3V1ZWT3poVEZxVDNVYkZFR2c1eVkwX0xoVW9tZw?oc=5" target="_blank">Why new cancer treatment discoveries are proliferating</a>  <font color="#6f6f6f">Penn Medicine</font>

Multiple Myeloma Trial Explores Immunotheraphy Option
Froedtert & MCWworld

Multiple Myeloma Trial Explores Immunotheraphy Option

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxPZ1FKWGp3NU94ZGppRDRxdlBrVzZWNlV4QWo2aXZ3bDRXTVUyVV9fVFZVVzN4WlBtdzZMOHhDVDlnQzUwV2ItMzhrdFlDelJUaWs4b2JMY2tvZEdfa1JKbjdXZXNKUEl2VVNkczZFTGF2NjZqSXVWLU05NnU5aDBIV0I4Wm1CcEdHQTEyMFpWdU8?oc=5" target="_blank">Multiple Myeloma Trial Explores Immunotheraphy Option</a>  <font color="#6f6f6f">Froedtert & MCW</font>

Peter Cook, PhD, on Exploring DARIC CAR T-Cells for Autoimmune Indications
CGTLive®world

Peter Cook, PhD, on Exploring DARIC CAR T-Cells for Autoimmune Indications

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxPQ0tURzQ0NzdDQkZCWmZQd0pkVU8ya21CcTZNUHByN1A3cGEwN2paX3NrMFgxYldfYTNoamNiV0gyWEJONmR6NUFkZk1wa0NIMm1mMmxkeHhwUzlyODNyTm95ODJFUzYxeXUxeUoxUzFCdzFOOTZodTVQT2FQbWltZy1vNFl5VVlZRHdPWQ?oc=5" target="_blank">Peter Cook, PhD, on Exploring DARIC CAR T-Cells for Autoimmune Indications</a>  <font color="#6f6f6f">CGTLive®</font>

Exploring the Potential of CAR T-Cell Therapy in Autoimmune Neurologic Diseases: Amanda Piquet, MD, FAAN
NeurologyLiveworld

Exploring the Potential of CAR T-Cell Therapy in Autoimmune Neurologic Diseases: Amanda Piquet, MD, FAAN

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQcF8tNE9ZYkNRb2VqQWpPajZBLXZLS1ZaSWdGUmNjYmo5Z1lvd2dGb2lCLW03YWlvWkVuejVJbWdrWjdSWVpVVmVUZHAyak1aTzV1eVhNazc5RktuQ2pnT05mSVB6aTdMbTZ3V1Y3TVhkSXpoeGd1aEFIVDNFUjQ0cGRGbm5Tbzc1RTR5cEdQb2lGVmxYMXhwWHFtVlZuQUFadHM2bWtKTTJhN19oY3JfZWI5RUpLb2JZbUE?oc=5" target="_blank">Exploring the Potential of CAR T-Cell Therapy in Autoimmune Neurologic Diseases: Amanda Piquet, MD, FAAN</a>  <font color="#6f6f6f">NeurologyLive</font>

In vivo CAR T: Faster, cheaper, and more effective cancer care
Drug Target Reviewgeneral

In vivo CAR T: Faster, cheaper, and more effective cancer care

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQZ1ZNdkZmQUpzOG9BYUlNQUd6ME1mMlIyZnAzamQtbTJTZ2tOMUVIV2Z5dVpjd3Vpb091OGJDX29JTTZ5M21JQlJlNHBGMmllbTVoMHRrSWNicVJHVDZ1ZDB1ai10bDRuMnR2Y3NoZUkzczNMdEwyRlFJWkNvbC1QTTZhX2U0S3pKeGZvX3BkOXVETXBJVjY2MC1RUWlyaTRzb2VPWGp4TnMxaGM?oc=5" target="_blank">In vivo CAR T: Faster, cheaper, and more effective cancer care</a>  <font color="#6f6f6f">Drug Target Review</font>

Tumor organoid-immune co-culture models: exploring a new perspective of tumor immunity
Natureworld

Tumor organoid-immune co-culture models: exploring a new perspective of tumor immunity

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1vcG9sRU5CaFR6cWRNY2Via3JjLVc3UnJJcC1aWS1BOXdRNl9IVzJZRVR4Mk51VkNEdU0tNTllSEN3OG1rMm8tWEtRNzVuQ0dCbzdrTmdMLW9lem1Td1BR?oc=5" target="_blank">Tumor organoid-immune co-culture models: exploring a new perspective of tumor immunity</a>  <font color="#6f6f6f">Nature</font>

Exploring CRISPR Technology To Enhance Cancer Immunotherapy
Harvard Medical Schooltech

Exploring CRISPR Technology To Enhance Cancer Immunotherapy

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNaHFjMjQwekgxSUpiY3JuejlTWVFGSlpIcU5ybWJZcE1LOVBXZ2NuRUJjZjZCMHQxcjRLSld1M085bXUxWU1GMGxfbldvUWlpaHBlZUFtWVVmOFZQTzNEWjVXendWSy1Qb0tkaV9tamxXWXRvQUhBanNLajBfR3VwUnJxS2ttTUx3YUppRTFn?oc=5" target="_blank">Exploring CRISPR Technology To Enhance Cancer Immunotherapy</a>  <font color="#6f6f6f">Harvard Medical School</font>

CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors
BioSpaceworld

CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxNR3ZydVNINzhiakRqN3BLTjZYaE5neVFLQzJCdG5qYjAzT1RnSnExcjAwNVZsaFhsTm0xS2lRSVBuUzJDd3NGM0lJZ29FLTliek02ajJyQTVoYzI4NUwyczNsVVRoc0JZTjktZGdDN0JwblZReXdfMEE5aFRiRFJ3MkRTaUM4SUJfSkhkY0V1cVNxTEhxTTg2MU4yeGFoV1VqclVjRFlpVjdvRm9aMV9GWG5YQUQyZW44OWl6bHhxNGRsRlRYZnFtem5CNUd3MkhvRENDTXY0WQ?oc=5" target="_blank">CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors</a>  <font color="#6f6f6f">BioSpace</font>

Zamto-Cel Represents Potential New CAR T Approach in R/R DLBCL
OncLivegeneral

Zamto-Cel Represents Potential New CAR T Approach in R/R DLBCL

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOOWRHZU1oYTRTcWg4a0dGNHZrSl9ILXQ5dHVOMWRPSzRjby16ZVRxZUxnREQyOTZYMGR2SHpUaHBRNVl3WElJNENQUmRScy1RdlV5dE9HSlhRZ2NYZ05uemRlR2tZZjlYcTVDcFk3NFFnNmo5dUV1LW5Ob3hnd2tDMmpjSklQQTZrZHFiSEd1d1EtaHdkNHc?oc=5" target="_blank">Zamto-Cel Represents Potential New CAR T Approach in R/R DLBCL</a>  <font color="#6f6f6f">OncLive</font>

"Exploring New CAR-T Appro" — Live Google News Trends & Headlines